semaglutide for ckd Ozempic picks up FDA indication to treat chronic kidney disease semaglutide and kidney disease Effects

Dietary interventions that reduce ultra-processed food intake and prioritize minimally processed nutrient-dense foods may represent a feasible, low-risk strategy to support mental health by restoring lipid balance and reducing neuroinflammatory burden

Semaglutide shows potential in reducing pain, inflammation, and improving metabolic health in endometriosis patients

Gastrointestinal reactions in the label are tied to dose level and escalation pace, which is why the labeled schedule starts at 0.25 mg weekly and steps up every four weeks

Impact of Glucagon-like Peptide-1 Receptor Agonists on Mental Illness: Evidence from a Mendelian Randomization Study